Drug Type Antibody drug conjugate (ADC) |
Synonyms WTX 212, WTX212 |
Target |
Mechanism BRAF G469V inhibitors(BRAF G469V inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Phase 1 | CN | 31 Oct 2022 | |
Solid tumor | Phase 1 | CN | 31 Oct 2022 | |
Liver Cancer | Preclinical | CN | - |
Phase 1 | 3 | onfoaezdde(kkbhqcuylc) = No treatment-related AEs greater than Grade 2 were observed biljbbbimy (hifmdokhfu ) | Positive | 31 May 2023 |